General Electric Company of the U.K. cleared up some of the speculation over its acquisition intentions with the announcement this month that it plans to acquire telecommunications company Reltec of Cleveland for $2.1 billion. The two companies signed a
General Electric Company of the U.K. cleared up some of the speculation over its acquisition intentions with the announcement this month that it plans to acquire telecommunications company Reltec of Cleveland for $2.1 billion. The two companies signed a definitive merger agreement March 1 that will be accomplished by a cash tender offer for all of Reltecs shares at $29.50 per share. In addition, Reltecs controlling shareholders, affiliates of Kohlberg Kravis Roberts of New York City, have entered into a stockholder agreement in which they will tender their 81.5% stake of Reltec to GEC.
Reltec has revenues of more than $1 billion and designs, manufactures, and sells telecommunications network products. The companys Cleveland headquarters are in the same city as that of GEC subsidiary Picker International. The deal would be a big move forward in GECs effort to reshape itself into a major player in the telecommunications and technology industries.
GECs future has been a source of speculation since January, when the company said it would sell its Marconi Electronics Systems subsidiary to British Aerospace for about $13 billion. The deal gave GEC roughly $4.5 billion in cash that it said it would use to strengthen its communications and technology interests.
GEC chairman George Simpson at one point speculated that his company could be interested in buying the medical electronics businesses of Siemens or Philips, an intention that was dismissed by representatives from both firms (SCAN 2/3/99). If the Reltec deal goes through, it would make the likelihood of such an acquisition more remote. GEC would still have enough cash to buy a small or mid-sized company, however, and the U.K. firm has been linked with several medical imaging vendors besides Siemens and Philips (SCAN 2/17/99).
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.